ASCO Plenary Feb 2022 - ASCO Plenary Series: February 2022
Feb 15 - Feb 15, 2022 | AlexandriaVAUS
LARVOL is not affiliated with ASCO Plenary Series: February 2022 and all trademarks, logos, and brand names are property of their respective owners
Condition
Product
MOA
Trial Name/ID
Showing 2 abstracts linked to Trials
A randomized phase III, double-blinded, placebo-controlled trial of aspirin as adjuvant therapy for breast cancer (A011502): The Aspirin after Breast Cancer (ABC) Trial
First data for sotorasib in patients with pancreatic cancer with KRAS p.G12C mutation: A phase I/II study evaluating efficacy and safety